Literature DB >> 9420286

Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles.

M Werr1, R Prange.   

Abstract

Unlike those of the S and the L envelope proteins, the functional role of the related M protein in the life cycle of the hepatitis B virus (HBV) is less understood. We now demonstrate that a single N glycan, specific for M, is required for efficient secretion of M empty envelope particles. Moreover, this glycan mediates specific association of M with the chaperone calnexin. Conversely, the N glycan, common to all three envelope proteins, is involved neither in calnexin binding nor in subviral particle release. As proper folding and trafficking of M need the assistance of the chaperone, the glycan-dependent association of M with calnexin may thus play a crucial role in the assembly of HBV. Beyond being modified by N glycosylation, M is modified by O glycosylation occurring within its amino acid sequence at positions 27 to 47. The O glycans, however, were found to be dispensable for secretion of M but may rather support viral infectivity. Surprisingly, nonglycosylated M localizes exclusively to the cytosol, either for degradation or for a yet-unknown function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420286      PMCID: PMC109435     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles.

Authors:  R Prange; R Nagel; R E Streeck
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles.

Authors:  K Ueda; T Tsurimoto; K Matsubara
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  The N-terminal (pre-S2) domain of a hepatitis B virus surface glycoprotein is translocated across membranes by downstream signal sequences.

Authors:  B E Eble; V R Lingappa; D Ganem
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

Review 4.  The pre-S region of hepadnavirus envelope proteins.

Authors:  A R Neurath; S B Kent
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

5.  The large surface protein of hepatitis B virus is retained in the yeast endoplasmic reticulum and provokes its unique enlargement.

Authors:  R Biemans; D Thines; T Rutgers; M De Wilde; T Cabezon
Journal:  DNA Cell Biol       Date:  1991-04       Impact factor: 3.311

6.  Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier.

Authors:  D Fernholz; P R Galle; M Stemler; M Brunetto; F Bonino; H Will
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

7.  Intracellular transport and secretion of hepatitis B surface antigen in mammalian cells.

Authors:  E J Patzer; G R Nakamura; A Yaffe
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

8.  Processing of hepatitis B virus surface antigen expressed by recombinant Oka varicella vaccine virus.

Authors:  K Shiraki; H Ochiai; S Matsui; N Aiba; Y Yoshida; T Okuno; K Yamanishi; M Takahashi
Journal:  J Gen Virol       Date:  1992-06       Impact factor: 3.891

9.  The role of envelope proteins in hepatitis B virus assembly.

Authors:  V Bruss; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

10.  Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment.

Authors:  A P Huovila; A M Eder; S D Fuller
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

View more
  28 in total

1.  Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum.

Authors:  M P Courageot; M P Frenkiel; C D Dos Santos; V Deubel; P Desprès
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B.

Authors:  Bidisha Mitra; Roshan J Thapa; Haitao Guo; Timothy M Block
Journal:  Antiviral Res       Date:  2018-08-24       Impact factor: 5.970

3.  Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.

Authors:  N Branza-Nichita; D Durantel; S Carrouée-Durantel; R A Dwek; N Zitzmann
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks.

Authors:  Pamela A Norton; Stephan Menne; Gomathinayagam Sinnathamby; Lucy Betesh; Paul J Cote; Ramila Philip; Anand S Mehta; Bud C Tennant; Timothy M Block
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

5.  Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.

Authors:  Qian Wu; Hai-Ou Liu; Yi-Dong Liu; Wei-Si Liu; Deng Pan; Wei-Juan Zhang; Liu Yang; Qiang Fu; Jie-Jie Xu; Jian-Xin Gu
Journal:  J Biol Chem       Date:  2014-11-24       Impact factor: 5.157

6.  The degradation pathway for the HBV envelope proteins involves proteolysis prior to degradation via the cytosolic proteasome.

Authors:  Yuanjie Liu; Tianlun Zhou; Ender Simsek; Timothy Block; Anand Mehta
Journal:  Virology       Date:  2007-08-23       Impact factor: 3.616

Review 7.  Host factors involved in hepatitis B virus maturation, assembly, and egress.

Authors:  Reinhild Prange
Journal:  Med Microbiol Immunol       Date:  2012-09-11       Impact factor: 3.402

8.  Drastic reduction in the production of subviral particles does not impair hepatitis B virus virion secretion.

Authors:  Tamako Garcia; Jisu Li; Camille Sureau; Kiyoaki Ito; Yanli Qin; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

9.  Inhibition of cellular alpha-glucosidases results in increased presentation of hepatitis B virus glycoprotein-derived peptides by MHC class I.

Authors:  Ender Simsek; Gomathinayagam Sinnathamby; Timothy M Block; Yuanjie Liu; Ramila Philip; Anand S Mehta; Pamela A Norton
Journal:  Virology       Date:  2008-12-16       Impact factor: 3.616

10.  Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus.

Authors:  Camille Sureau; Chantal Fournier-Wirth; Patrick Maurel
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.